Thromb Haemost 1993; 70(01): 029-035
Schattauer GmbH Stuttgart
Molecular Events that Control the Protein C Anticoagulant Pathway
Charles T Esmon
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation; Departments
of Pathology and Biochemistry, University of Oklahoma Health Sciences Center, and
Howard Hughes Medical Institute, Oklahoma City, OK, USA
› Author Affiliations
References
1
Kisiel W.
Human plasma protein C: isolation, characterization and mechanism of activation by
α-thrombin. J Clin Invest 1979; 64: 761-769 2
Dittman WA.
Thrombomodulin: Biology and potential cardiovascular applications. Trends Cardiovasc
Med 1991; 1: 331-336 3
Esmon CT.
The roles of Protein C and thrombomodulin in the regulation of blood coagulation.
J Biol Chem 1989; 264: 4743-4746 4
Parkinson JF,
Koyama T,
Bang NU,
Preissner KT.
Thrombomodulin: An anticoagulant cell surface proteoglycan with physiologically relevant
glycosaminoglycan moiety. Adv Exp Med Biol 1992; 313: 177-188 5
Gailani D,
Broze Jr GJ.
Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912
6
Kurosawa S,
Stearns DJ,
Jackson KW,
Esmon CT.
A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain
of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem 1988;
263: 5993-5996 7
Stearns DJ,
Kurosawa S,
Esmon CT.
Micro-thrombomodulin: Residues 310-486 from the epidermal growth factor precursor
homology domain of thrombomodulin will accelerate protein C activation. J Biol Chem
1989; 264: 3352-3356 8
Zushi M,
Gomi K,
Yamamoto S,
Maruyama I,
Hayashi T,
Suzuki K.
The last three consecutive epidermal growth factor-like structures of human thrombomodulin
comprise the minimum functional domain for protein C-activating cofactor activity
and anticoagulant activity. J Biol Chem 1989; 264: 10351-10353 9
Parkinson JF,
Nagashima M,
Kuhn I,
Leonard J,
Morser J.
Structure-function studies of the epidermal growth factor domains of human thrombomodulin
. Biochem Biophys Res Commun 1992; 185: 567-576 10
Grinnell BW,
Walls JD,
Gerlitz B,
Berg DT,
McClure DB,
Ehrlich H,
Bang NU,
Yan SB.
Native and modified recombinant human protein C: Function, secretion, and posttranslational
modifications. In: Protein C and Related Anticoagulants (Advances in Applied Biotechnology
Series, vol. 11).
Bruley DF,
Drohan WN.
(eds). Gulf Publishing Company; Houston: 1991. pp. 29-63 11
Dolan G,
Ball J,
Preston FE.
Protein C and protein S. Clin Haematol 1989; 2: 999-1042 12
Walker FJ,
Fay PJ.
Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567
13
Preissner KT.
Biological relevance of the protein C system and laboratory diagnosis of protein C
and protein S deficiencies. Clin Science 1990; 78: 351-364 14
Pabinger I,
Brucker S,
Kyrle PA,
Schneider B,
Korninger HC,
Niessner H,
Lechner K.
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in
patients with a history of venous thrombosis and criteria for rational patient screening.
Blood Coag Fibrinol 1992; 3: 547-553 15
Rodgers GM,
Chandler WL.
Laboratory and clinical aspects of inherited thrombotic disorders. Am J Hematol 1992;
41: 113-122 16
Comp PC,
Esmon CT.
Regulatory mechanisms in hemostasis: Natural anticoagulants. In: Hematology: Basic
Principles and Practice.
Hoffman R,
Benz Jr. EJ,
Shattil SJ,
Furie B,
Cohen HJ.
(eds).
Churchill Livingstone; New York: 1991. pp. 1243-1251 17
Stenflo J.
Structure-function relationships of epidermal growth factor modules in vitamin K-dependent
clotting factors. Blood 1991; 78: 1637-1651 18
Davie EW,
Fujikawa K,
Kisiel W.
The coagulation cascade: Initiation, maintenance and regulation. Biochemistry 1991;
30: 10363-10370 19
Bode W,
Turk D,
Karshikov A.
The refined 1.9-Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited
human alpha-thrombin: Structure analysis, overall structure, electrostatic properties,
detailed active-site geometry, and structure-function relationships. Protein Sci 1992;
1: 426-471 20
Qiu X,
Padmanabhan KP,
Carperos VE,
Tulinsky A,
Kline T,
Maraganore JM,
Fenton II JW.
Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates
and inhibitors. Biochemistry 1992; 31: 11689-11697 21
Stubbs MT,
Oschkinat H,
Mayr I,
Huber R,
Angliker H,
Stone SR,
Bode W.
The interaction of thrombin with fibrinogen. A structural basis for its specificity.
Eur J Biochem 1992; 206: 187-195 22
Petersen TE.
The amino-terminal domain of thrombomodulin and pancreatic stone protein are homologous
with lectins. FEBS Lett 1988; 231: 51-53 23
Ye J,
Liu LW,
Esmon CT,
Johnson AE.
The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion
exosite of thrombin and alter its specificity. J Biol Chem 1992; 267: 11023-11028
24
Suzuki K,
Nishioka J,
Hayashi T.
Localization of thrombomod-ulin-binding site within human thrombin. J Biol Chem 1990;
265: 13263-13267 25
Tsiang M,
Lentz SR,
Dittman WA,
Wen D,
Scarpati EM,
Sadler JE.
Equilibrium binding of thrombin to recombinant human thrombomodulin: Effect of hirudin,
fibrinogen, factor Va and peptide analogues. Biochemistry 1990; 29: 10602-10612 26
Hayashi T,
Zushi M,
Yamamoto S,
Suzuki K.
Further localization of binding sites for thrombin and protein C in human thrombomodulin.
J Biol Chem 1990; 265: 20156-20159 27
Bourin MC,
Öhlin AK,
Lane DA,
Stenflo J,
Lindahl U.
Relationship between anticoagulant activities and polyanionic properties of rabbit
thrombomodulin. J Biol Chem 1988; 263: 8044-8052 28
Ye J,
Esmon CT,
Johnson AE.
The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin.
J Biol Chem 1993; 268: 2373-2379 29
Preissner KT,
Delvos U,
Muller-Berghaus G.
Binding of thrombin to thrombomodulin accelerates inhibition of enzyme by antithrombin
III.Evidence for a heparin-independent mechanism. Biochemistry 1987; 26: 2521-2528
30
Jackman RW,
Beeler DL,
Fritze L,
Soff G,
Rosenberg RD.
Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and
gene predict protein structure and suggest sites of regulatory control. Proc Natl
Acad Sci USA 1987; 84: 6425-6429 31
Wen D,
Dittman WA,
Ye RD,
Deaven LL,
Majerus PW,
Sadler JE.
Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene.
Biochemistry 1987; 26: 4350-4357 32
Suzuki K,
Kusumoto H,
Deyashiki Y,
Nishioka J,
Maruyama I,
Zushi M,
Kawahara S,
Honda G,
Yamamoto S,
Horiguchi S.
Structure and expression of human thrombomodulin, a thrombin receptor on endothelium
acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-1897 33
Armstrong SA,
Husten EJ,
Esmon CT,
Johnson AE.
The active site of membrane-bound meizothrombin: A fluorescence determination of its
distance from the phospholipid surface and its conformational sensitivity to calcium
and factor Va. J Biol Chem 1990; 265: 6210-6218 34
Husten EJ,
Esmon CT,
Johnson AE.
The active site of blood coagulation factor Xa: its distance from the phospholipid
surface and its conformational sensitivity to components of the prothrombinase complex.
J Biol Chem 1987; 262: 12953-12962 35
Mutucumarana VP,
Duffy EJ,
Lollar P,
Johnson AE.
The active site of factor IXa is located far above the membrane surface and its conformation
is altered upon association with factor Villa: A fluorescence study. J Biol Chem 1992;
267: 17012-17021 36
Luckow EA,
Lyons DA,
Ridgeway TM,
Esmon CT,
Laue TM.
Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and
role of activated protein C in regulating this interaction: Analysis by analytical
ultracentrifugation. Biochemistry 1989; 28: 2348-2354 37
Guinto ER,
Esmon CT.
Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor
Va by activated protein C. J Biol Chem 1984; 259: 13986-13992 38
Evans DL,
Marshall CJ,
Christey PB,
Carrell RW.
Heparin binding site, conformational change, and activation of antithrombin. Biochemistry
1992; 31: 12629-12642 39
Jakubowski HV,
Kline MD,
Owen WG.
The effect of bovine thrombomodulin on the specificity of bovine thrombin. J Biol
Chem 1986; 261: 3876-3882 40
Musci G,
Berliner LJ,
Esmon CT.
Evidence for multiple conformational changes in the active center of thrombin induced
by complex formation with thrombomodulin: An analysis employing nitroxide spin labels.
Biochemistry 1988; 27: 769-773 41
Ye J,
Esmon NL,
Esmon CT,
Johnson AE.
The active site of thrombin is altered upon binding to thrombomodulin: Two distinct
structural changes are detected by fluorescence, but only one correlates with protein
C activation. J Biol Chem 1991; 266: 23016-23021 42
Zushi M,
Gomi K,
Honda G,
Kondo S,
Yamamoto S,
Hayashi T,
Suzuki K.
Aspartic acid 349 in the fourth epidermal growth factorlike structure of human thrombomodulin
plays a role in its Ca2+ -medi-ated binding to protein C. J Biol Chem 1991; 266: 19886-19889 43
Le Bonniec BF,
MacGillivray RTA,
Esmon CT.
Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues. J Biol Chem 1991;
266: 13796-13803 44
Le Bonniec BF,
Esmon CT.
Glu-192 [to] Gin substitution in thrombin mimics the catalytic switch induced by thrombomodulin.
Proc Natl Acad Sci USA 1991; 88: 7371-7375 45
Rezaie AR,
Esmon CT.
The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin
complex can be distinguished by mutational analysis of protein C derivatives. J Biol
Chem 1992; 267: 26104-26109 46
Ehrlich HJ,
Grinnell BW,
Jaskunas SR,
Esmon CT,
Yan SB,
Bang NU.
Recombinant human protein C derivatives: altered response to calcium resulting in
enhanced activation by thrombin. EMBO J 1990; 9: 2367-2373 47
Richardson MA,
Gerlitz B,
Grinnell BW.
Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant.
Nature 1992; 360: 261-264 48
Guinto ER,
Le Bonniec BF,
Esmon CT.
The role of motif PPW in thrombin functions. Circulation 1992; 86: 1-412 49
Le Bonniec BF,
Guinto ER,
Esmon CT.
Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin
and protein C. J Biol Chem 1992; 267: 19341-19348 50
Bode W,
Mayr I,
Baumann U,
Huber R,
Stone SR,
Hofsteenge J.
The refined 1.9 A crystal structure of human a-thrombin: interaction with D-Phe-Pro-Arg
chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO
J 1989; 8: 3467-3475 51
Amphlett GW,
Kisiel W,
Castellino FJ.
Interaction of calcium with bovine plasma protein C. Biochemistry 1981; 20: 2156-2161
52
Esmon NL,
DeBault LE,
Esmon CT.
Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein
C. J Biol Chem 1983; 258: 5548-5553 53
Stearns DJ,
Kurosawa S,
Sims PJ,
Esmon NL,
Esmon CT.
The interaction of a Ca2+ dependent monoclonal antibody with the protein C activation peptide region: Evidence
for obligatory Ca2+ binding to both antigen and antibody. J Biol Chem 1988; 263: 826-832 54
Persson E,
Selander M,
Linse S,
Drakenberg T,
Öhlin AK,
Stenflo J.
Calcium binding to the isolated β-hydroxyaspartic acid-containing epidermal growth
factor-like domain of bovine factor X. J Biol Chem 1989; 264: 16897-16904 55
Ullner M,
Selander M,
Persson E,
Stenflo J,
Drakenberg T,
Teleman O.
Three-dimensional structure of the Apo form of the N-terminal EGF-like module of blood
coagulation factor X as determined by NMR spectroscopy and simulated folding. Biochemistry
1992; 31: 5974-5983 56
Selander-Sunnerhagen M,
Ullner M,
Persson E,
Teleman O,
Stenflo J,
Drakenberg T.
How an epidermal growth factor (EGF)-like domain binds calcium: High resolution NMR
structure of the calcium form of the NH2 -terminal EGF-like domain in coagulation factor X. J Biol Chem 1992; 267: 19642-19649
57
Handford PA,
Mayhew M,
Baron M,
Winship PR,
Campbell ID,
Brownlee GG.
Key residues involved in calcium-binding motifs in EGF-like domains. Nature 1991;
351: 164-167 58
Öhlin AK,
Stenflo J.
Calcium-dependent interaction between the EGF region of human protein C and a monoclonal
antibody. J Biol Chem 1987; 262: 13798-13804 59
Öhlin AK,
Linse S,
Stenflo J.
Calcium binding to the epidermal growth factor homology region of bovine protein C.
J Biol Chem 1988; 263: 7411-7417 60
Öhlin AK,
Landes G,
Bourdon P,
Oppenheimer C,
Wydro R,
Stenflo J.
β-Hydroxyaspartic acid in the first epidermal growth factor-like domain of protein
C: Its role in Ca2+ binding and biological activity. J Biol Chem 1988; 263: 19240-19248 61
Sugo T,
Bjork I,
Holmgren A,
Stenflo J.
Calcium-binding properties of bovine factor X lacking the gamma-carboxyglutamic acid-containing
region. J Biol Chem 1984; 259: 5705-5710 62
Rezaie AR,
Esmon NL,
Esmon CT.
The high affinity calcium-binding site involved in protein C activation is outside
the first epidermal growth factor homology domain. J Biol Chem 1992; 267: 11701-11704
63
Persson E,
Bjork I,
Stenflo J.
Protein structural requirements for Ca2+ binding to the light chain of factor X. Studies using isolated intact fragments containing
the gamma-carboxyglutamic acid region and/or the epidermal growth factor-like domains.
J Biol Chem 1991; 266: 2444-2452 64
Rezaie AR,
Neuenschwander PF,
Morrissey JH,
Esmon CT.
Analysis of the functions of the first epidermal growth factor-like domain of factor
X. J Biol Chem. 1993 (In Press) 65
McCord DM,
Monroe DM,
Smith KJ,
Roberts HR.
Characterization of the functional defect in factor IX Alabama: Evidence for a conformational
change due to high affinity calcium binding in the first epidermal growth factor domain.
J Biol Chem 1990; 265: 10250-10254 66
Bourin MC,
Lundgren-Åkerlund E,
Lindahl U.
Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin
proteoglycan. J Biol Chem 1990; 265: 15424-15431 67
Parkinson JF,
Vlahos CJ,
Yan SCB,
Bang NU.
Recombinant human thrombomodulin: Regulation of cofactor activity and anticoagulant
function by a glycosaminoglycan side chain. Biochem J 1992; 283: 151-157 68
Bourin MC.
Effect of rabbit thrombomodulin on thrombin inhibition by antithrombin in the presence
of heparin. Thromb Res 1989; 54: 27-39 69
Bourin MC,
Bjork I,
Boffa MC,
Lindahl U.
Effect of rabbit thrombomodulin on the inhibition of thrombin by antithrombin in the
presence of exogenous heparin: Role of the acidic domain of thrombomodulin. Thromb
Haemostas 1987; 58: 320 (Abstr.). 70
Kurosawa S,
Galvin JB,
Esmon NL,
Esmon CT.
Proteolytic formation and properties of functional domains of thrombomodulin. J Biol
Chem 1987; 262: 2206-2212 71
Parkinson JF,
Grinnell BW,
Moore RE,
Hoskins J,
Vlahos CJ,
Bang NU.
Stable expression of a secretable deletion mutant of recombinant human thrombomodulin
in mammalian cells. J Biol Chem 1990; 265: 12602-12610 72
Hogg PJ,
Öhlin AK,
Stenflo J.
Identification of structural domains in protein C involved in its interaction with
thrombin-thrombomodulin on the surface of endothelial cells. J Biol Chem 1992; 267:
703-706 73
Olsen PH,
Esmon NL,
Esmon CT,
Laue TM.
The Ca2+ -dependence of the interactions between protein C, thrombin and the elastase fragment
of thrombomodulin. Analysis by ultracentrifugation. Biochemistry 1992; 31: 746-754
74
Ruf W,
Rehemtulla A,
Morrissey JH,
Edgington TS.
Phospho-lipid-independent and dependent interactions required for tissue factor receptor
and cofactor function. J Biol Chem 1991; 266: 2158-2166 75
Nesheim ME,
Eid S,
Mann KG.
Assembly of the prothrombinase complex in the absence of prothrombin. J Biol Chem
1981; 256: 9874-9882 76
Shigematsu Y,
Miyata T,
Higashi S,
Miki T,
Sadler JE,
Iwanaga S.
Expression of human soluble tissue factor in yeast and enzymatic properties of its
complex with factor VIIa. J Biol Chem 1992; 267: 21329-21337 77
Higgins DL,
Lewis SD,
Shafer JA.
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen
to fibrin. J Biol Chem 1983; 258: 9276-9282 78
Galvin JB,
Kurosawa S,
Moore K,
Esmon CT,
Esmon NL.
Reconsti-tution of rabbit thrombomodulin into phospholipid vesicles. J Biol Chem 1987;
262: 2199-2205
